A Study of Axitinib in Advanced Carcinoid Tumors

NCT01435122 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Carcinoid Tumor

Interventions

DRUG: Axitinib

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]